Electra Therapeutics, Inc. (ETRA)
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Medical - Pharmaceuticals
Electra Therapeutics Inc.
NASDAQ:ETRAHealthcare · Medical - Pharmaceuticals
-6.25%$8.10
AH$8.10+0.00%vs close
Mkt Cap$508.41M
Float34.42M
O/S62.77M
Vol
$ Vol
RVOL
Inst Own0.0%
SI1.2%
Earnings
Dilution
MCap$508.41M
Float34.42M
O/S62.77M
Dilution
Financials Summary
No financial data available.
Debt & Equity
No debt & equity data available.
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in ETRA's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
No balance sheet details available.
Income Statement
No income statement data available.
Balance Sheet
No balance sheet data available.
Cash Flow Statement
No cash flow data available.